Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03186274 · ClinicalTrials.gov registry record · NA
Discussing Death and Dying: An End of Life Curriculum to Empower Residents
A NA study of Education, Medical and Education, Medical, Graduate, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 1
- Study location
NCT03186274: Completed NA study of Education, Medical and Education, Medical, Graduate, sponsored by Vanderbilt University Medical Center.
NCT03186274 is a NA study of Education, Medical and Education, Medical, Graduate that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 37 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03186274, a NA study of Education, Medical and Education, Medical, Graduate, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate how the educational intervention utilized affects pediatric resident comfort level with EOL discussions.
Primary Outcome
Residents will complete validated pre- and post-surveys to evaluate their competency in having end of life discussions. The scale is 1-4, where 1 indicates very comfortable and 4 indicates very uncomfortable.
Conditions Studied
Interventions
- BEHAVIORAL Facilitated Group Session
- BEHAVIORAL CELA Session
Study Locations (1)
Tennessee
- Monroe Carell Junior Children's Hospital at Vanderbilt - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2017-06-26 |
| Est. Completion | 2018-07-01 |
| Phase | NA |
What the finished NCT03186274 record still lists
NCT03186274 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 4 conditions, with Education, Medical appearing as the primary indexed condition, and to 2 interventions - of which Facilitated Group Session is the first listed.
NCT03186274 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT03186274 about?
NCT03186274 is a clinical study titled "Discussing Death and Dying: An End of Life Curriculum to Empower Residents". This study will evaluate how the educational intervention utilized affects pediatric resident comfort level with EOL discussions.
What is the current status of trial NCT03186274?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2017-06-26. Estimated completion is 2018-07-01.
What conditions does trial NCT03186274 study?
This clinical trial studies the following conditions: Education, Medical, Education, Medical, Graduate, Care, Palliative, Medicine, Palliative.
What interventions are being tested in trial NCT03186274?
The interventions under investigation include: Facilitated Group Session (BEHAVIORAL), CELA Session (BEHAVIORAL).
Who is sponsoring clinical trial NCT03186274?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03186274 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Education, Medical
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03186274's enrollment target sits among peer trials
37 1540th of 2000 higher than 460 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI